The upregulation of immune checkpoint proteins, such as PD-L1, in both tumor and stromal cells within the bone further prevents effective immune surveillance, undermining the efficacy of immune checkpoint inhibitors [83]. The gene discussed is CD274; the disease is neoplasm.